SoFi, in partnership with Templum, has opened a limited‑time private‑market investment window for accredited investors. The window, launched on March 5 2026, gives members access to three high‑profile private companies—Colossal Biosciences, OpenAI, and Perplexity AI—through the Cosmos Fund.
The Cosmos Fund, managed by Templum, will run from March 5 through March 30 2026. Members can invest in each of the three companies, which span biotech, artificial intelligence, and AI‑search technology, providing a diversified exposure to cutting‑edge private‑market opportunities.
This launch marks a significant expansion of SoFi’s product suite. By adding a private‑market channel, SoFi can tap into fee‑based revenue streams that complement its traditional lending and banking services. The move also reinforces the company’s “one‑stop shop” strategy, aiming to deepen member engagement and attract new accredited investors seeking exclusive access to high‑growth private firms.
The announcement was part of a day of positive news for SoFi, which also revealed a partnership with Mastercard to launch a stablecoin initiative. The combined announcements signal the company’s continued focus on expanding its financial services footprint and leveraging technology partnerships to create new revenue avenues.
CEO Anthony Noto, in a Q4 2025 earnings release, said, “Our one‑stop shop is scaling exactly as intended and delivering a winning combination of growth and returns.” The new private‑market offering aligns with that narrative, illustrating SoFi’s commitment to broadening its platform and delivering value to its member base.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.